Buy & Sell Recursion Pharmaceuticals Inc (RXRX) – Recursion Pharmaceuticals Inc Price Today
Aura AI Summary
Key Stats
- $1.86BMarket Cap
- HealthSector
- -24.6%3M Drawdown
- $1.28BEnterprise Value
- -Dividend Yield
- 12 daysTypical Hold Time
Recursion Pharmaceuticals Inc (RXRX) is currently valued at a market capitalization of $1.86B, with an enterprise value of $1.28B. Over the past 52 weeks, Recursion Pharmaceuticals Inc has traded between a low of $2.84 and a high of $6.79, highlighting its annual price range. Over the past three months, Recursion Pharmaceuticals Inc has recorded a drawdown of -24.6%, reflecting recent price volatility. On average, investors hold Recursion Pharmaceuticals Inc for approximately 12 days, indicating typical investor behavior on the platform.
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Most Recent News
Whey protein shortages hit U.S. as demand spikes from weight-loss drugs and diet trends.
Whey protein inventories in the U.S. have dropped about 50% since 2023 due to surging demand driven by diet trends and increased use of GLP-1 weight-loss drugs, which require higher protein intake to prevent muscle loss. The dairy industry's processi...
Micron nears top US profit ranks thanks to soaring AI memory chip demand.
Micron Technology has transformed from losing money three years ago to becoming one of the most profitable companies in the U.S. This turnaround is driven by the booming demand for memory chips essential to artificial intelligence, with AI companies ...
June jobs report to shape markets and Fed policy ahead of September meeting
The June jobs report is expected to be a key event influencing interest rates, currencies, and risk assets through September. A stronger-than-expected report could prompt the Federal Reserve to tighten monetary policy further, flatten the yield curve...